AFT-Leflunomide

Country: Նոր Զելանդիա

language: անգլերեն

source: Medsafe (Medicines Safety Authority)

active_ingredient:

Leflunomide 20mg;  

MAH:

AFT Pharmaceuticals Ltd

INN:

Leflunomide 20 mg

dosage:

20 mg

pharmaceutical_form:

Film coated tablet

composition:

Active: Leflunomide 20mg   Excipient: Colloidal silicon dioxide Crospovidone Lactose monohydrate Maize starch Opadry yellow 85F12305 Povidone Purified talc

units_in_package:

Bottle, plastic, HDPE with PP screw cap, 30 tablets, 30 tablets

class:

Prescription

prescription_type:

Prescription

manufactured_by:

Formosa Laboratories Inc.

therapeutic_indication:

AFT-LEFLUNOMIDE is indicated for treating rheumatoid arthritis, for improving signs and symptoms of the disease, for retarding joint destruction and also for improving functionality and the quality of life. AFT-LEFLUNOMIDE can be used with patients who have not responded to alternative treatments or as a first line treatment in patients who have a contraindication to other medicines.

leaflet_short:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with PP screw cap, 30 tablets - 30 tablets - 24 months from date of manufacture stored at or below 25°C protect from light - Bottle, plastic, HDPE with PP screw cap, 100 tablets - 100 tablets - 24 months from date of manufacture stored at or below 25°C protect from light

authorization_date:

2005-09-20